Weekly Policy Update: President Moves Forward with Most-Favored-Nation Drug Pricing Policy
By: Colorado BioScience Association Date: 09/14/2020
On Sunday, President Trump issued an Executive Order on a drug pricing policy called “most-favored-nation.” The order directs the Secretary of Health and Human Services (HHS) to develop and implement...
Learn MoreColorado Partners with Google and Apple to Launch Contact Tracing App
By: Colorado BioScience Association Date: 09/11/2020
At a press conference on Tuesday, Governor Jared Polis announced that Colorado will partner with Google and Apple on a contact tracing app for COVID-19. By the end of September, any resident with a sm...
Learn MoreWeekly Policy Update: CMS Issues Proposed Rule to Improve Coverage for Breakthrough Technologies
By: Colorado BioScience Association Date: 09/04/2020
This week the Centers for Medicare & Medicaid Services (CMS) released the long-awaited proposed rule on "Medicare Coverage of Innovative Technologies." The proposed rule would make significant cha...
Learn MoreWeekly Policy Update: CBSA Member PharmaJet Hosts Visit with Senator Cory Gardner
By: Colorado BioScience Association Date: 08/28/2020
CBSA member PharmaJet hosted a visit with U.S. Senator Cory Gardner this week to showcase their needle-free technology for vaccine and therapeutic delivery. It was a great opportunity for the company...
Learn MoreWeekly Policy Update: CBSA Engages Congressional Delegation to Protect Life Sciences Innovation
By: Colorado BioScience Association Date: 08/21/2020
CBSA continues to engage the Colorado Congressional delegation around an executive order that the President announced on July 24 that would limit payment for Medicare Part B drugs to the lowest price...
Learn MoreWeekly Policy Update: President Trump Issues ‘Buy American’ Executive Order
By: Colorado BioScience Association Date: 08/16/2020
President Trump recently issued an executive order intended to increase federal support for the domestic manufacture of “essential medicines,” “medical countermeasures,” and “critical inputs” through...
Learn MoreWeekly Policy Update: CBSA Advocates for Additional Relief for Life Sciences Startups + Growth Companies
By: Colorado BioScience Association Date: 08/07/2020
CBSA supports H.R. 7917, the IGNITE American Innovation Act, bipartisan legislation recently introduced to ensure innovative and entrepreneurial companies can access the necessary liquidity to continu...
Learn MoreWeekly Policy Update: CBSA Meets with Congressional Offices on the VALID Act
By: Colorado BioScience Association Date: 07/31/2020
CBSA and our members met with Senator Michael Bennet and Rep. Diana DeGette’s offices this week to discuss the Verifying Accurate Leading-edge IVCT Development (VALID) Act, recent federal legislation...
Learn MoreWeekly Policy Update: Energize Colorado Gap Fund Launches August 2020
By: Colorado BioScience Association Date: 07/24/2020
The Energize Colorado Gap Fund was created by Senate Bill 222 and will provide more than $25 million in small business loans and grants to boost small businesses impacted by COVID-19. Sole propr...
Learn MoreWeekly Policy Update: Federal Lawmakers Introduce Diagnostic Testing Bills
By: Colorado BioScience Association Date: 07/17/2020
Recently, Colorado Representative Diana DeGette and Indiana Representative Larry Bucshon introduced two bills to increase diagnostic testing capabilities at public health laboratories, in hospitals, a...
Learn More